Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer

World Journal of Gastroenterology

Volumn 20, Issue 8, 2014, Pages 2005-2013

  Seo, Young Seok ^a   Kim, Mi Sook ^a   Yoo, Hyung Jun ^a   Jang, Won Il ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

Colorectal cancer; Lymph node; Oligo recurrence; Oligometastases; Stereotactic radiotherapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; OXALIPLATIN;

CANCER PROGNOSIS; COLORECTAL CANCER; CONE BEAM COMPUTED TOMOGRAPHY; DISEASE COURSE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; METASTASIS RESECTION; MORBIDITY; MORTALITY; PARAAORTIC LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; TISSUE INJURY; TUMOR VOLUME; COLORECTAL NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODE; METASTASIS; PATHOLOGY; RADIOSURGERY; SECONDARY; TREATMENT OUTCOME; TUMOR RECURRENCE;

COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODES; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; TREATMENT OUTCOME;

EID: 84894588841     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i8.2005     Document Type: Review

References (88)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078 DOI: 10.3322/canjclin.55.2.74]
2. Sung J. Colorectal cancer screening: its time for action in Asia. Cancer Detect Prev 2007; 31: 1-2 [PMID: 17339084 DOI: 10.1016/j.cdp.2007.01.002]
3. Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005; 6: 871-876 [PMID: 16257795 DOI: 10.1016/ S1470-2045(05)70422-8]
4. Pourhoseingholi MA. Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol 2012; 4: 68-70 [PMID: 22532878 DOI: 10.4251/wjgo.v4.i4.68]
5. Delpero JR, Pol B, Le Treut P, Bardou VJ, Moutardier V, Hardwigsen J, Granger F, Houvenaeghel G. Surgical resection of locally recurrent colorectal adenocarcinoma. Br J Surg 1998; 85: 372-376 [PMID: 9529496 DOI: 10.1046/ j.1365-2168.1998.00583.x]
6. Tepper JE, O'Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. J Clin Oncol 2003; 21: 3623-3628 [PMID: 14512393 DOI: 10.1200/JCO.2003.03.018]
7. Kim MS, Keum KC, Rhee WJ, Kim H, Kim M, Choi S, Nam KC, Koom WS. The location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancer. Radiat Oncol J 2013; 31: 97-103 [PMID: 23865006 DOI: 10.3857/ roj.2013.31.2.97]
8. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995; 13: 8-10 [PMID: 7799047]
9. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol 2011; 8: 378-382 [PMID: 21423255 DOI: 10.1038/nrclinonc.2011.44]
10. Niibe Y, Hayakawa K. Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol 2010; 40: 107-111 [PMID: 20047860 DOI: 10.1093/jjco/hyp167]
11. Kanemitsu Y, Kato T, Hirai T, Yasui K. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 2004; 91: 112-120 [PMID: 14716804 DOI: 10.1002/bjs.4370]
12. Higashiyama M, Kodama K, Higaki N, Takami K, Murata K, Kameyama M, Yokouchi H. Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis. Jpn J Thorac Cardiovasc Surg 2003; 51: 289-296 [PMID: 12892459 DOI: 10.1007/BF02719380]
13. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 2007; 84: 324-338 [PMID: 17588454 DOI: 10.1016/j.athoracsur.2007. 02.093]
14. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-22, discussion 722-4 [PMID: 15849507]
15. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-18; discussion 318-21 [PMID: 10493478 DOI: 10.1097/00000658-199909000-00004]
16. Shibata D, Paty PB, Guillem JG, Wong WD, Cohen AM. Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma. Dis Colon Rectum 2002; 45: 795-801 [PMID: 12072633 DOI: 10.1007/s10350-004-6300-3]
17. Wanebo HJ, Koness RJ, Vezeridis MP, Cohen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer. Ann Surg 1994; 220: 586-95; discussion 595-7 [PMID: 7524455 DOI: 10.1097/00000658-199410000-00017]
18. Gunderson LL, Sosin H. Areas of failure found at reopera-tion (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974; 34: 1278-1292 [PMID: 4424091]
19. Bakx R, Visser O, Josso J, Meijer S, Slors JF, van Lanschot JJ. Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol 2008; 14: 6018-6023 [PMID: 18932280 DOI: 10.3748/wjg.14.6018]
20. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman B, Senan S. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol 2011; 101: 240-244 [PMID: 21775007 DOI: 10.1016/j.radonc.2011.06.029]
21. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070-1076 [PMID: 20233825 DOI: 10.1001/jama.2010.261]
22. Louie AV, Rodrigues G, Hannouf M, Lagerwaard F, Palma D, Zaric GS, Haasbeek C, Senan S. Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis. Radiother Oncol 2011; 99: 161-165 [PMID: 21620503 DOI: 10.1016/j.radonc.2011.04.005]
23. Mohammed N, Grills IS, Wong CY, Galerani AP, Chao K, Welsh R, Chmielewski G, Yan D, Kestin LL. Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors. Radiother Oncol 2011; 99: 18-22 [PMID: 21458087 DOI: 10.1016/j.radonc.2011.03.003]
24. Andratschke N, Zimmermann F, Boehm E, Schill S, Schoenknecht C, Thamm R, Molls M, Nieder C, Geinitz H. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. Radiother Oncol 2011; 101: 245-249 [PMID: 21724287 DOI: 10.1016/ j.radonc.2011.06.009]
25. McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg 1985; 72: 34-37 [PMID: 3967128 DOI: 10.1002/bjs.1800720115]
26. Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker WE. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 1984; 53: 1354-1362 [PMID: 6692324]
27. Rao AR, Kagan AR, Chan PM, Gilbert HA, Nussbaum H, Hintz BL. Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon. Cancer 1981; 48: 1492-1495 [PMID: 7272970]
28. Bozzetti F, Bertario L, Rossetti C, Gennari L, Andreola S, Baratti D, Gronchi A. Surgical treatment of locally recurrent rectal carcinoma. Dis Colon Rectum 1997; 40: 1421-1424 [PMID: 9407978 DOI: 10.1007/BF02070705]
29. Eble MJ, Lehnert T, Treiber M, Latz D, Herfarth C, Wannenmacher M. Moderate dose intraoperative and external beam radiotherapy for locally recurrent rectal carcinoma. Radiother Oncol 1998; 49: 169-174 [PMID: 10052883 DOI: 10.1016/ S0167-8140(98)00124-8]
30. Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane CH, Janjan N, Skibber JM. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 2006; 49: 175-182 [PMID: 16392024 DOI: 10.1007/ s10350-005-0276-5]
31. Akasu T, Yamaguchi T, Fujimoto Y, Ishiguro S, Yamamoto S, Fujita S, Moriya Y. Abdominal sacral resection for posterior pelvic recurrence of rectal carcinoma: analyses of prognostic factors and recurrence patterns. Ann Surg Oncol 2007; 14: 74-83 [PMID: 17061173 DOI: 10.1245/s10434-006-9082-0]
32. Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O'Connell MJ, Cha S, Sargent DJ, Horgan A. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003; 237: 502-508 [PMID: 12677146 DOI: 10.1097/01.SLA.0000059972.90598.5F]
33. Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE, Guillem JG, Weiser MR, Cohen AM, Minsky BD, Wong WD, Temple LK. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 2006; 49: 1099-1107 [PMID: 16779712 DOI: 10.1007/s10350-006-0563-9]
34. Palmer G, Martling A, Cedermark B, Holm T. A populationbased study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007; 14: 447-454 [PMID: 17139457 DOI: 10.1245/s10434-006-9256-9]
35. Wanebo HJ, Antoniuk P, Koness RJ, Levy A, Vezeridis M, Cohen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 1999; 42: 1438-1448 [PMID: 10566532 DOI: 10.1007/ BF02235044]
36. Wiig JN, Poulsen JP, Larsen S, Braendengen M, Waehre H, Giercksky KE. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg 2002; 168: 42-48 [PMID: 12022371 DOI: 10.1080/11 0241502317307562]
37. Willett CG, Shellito PC, Tepper JE, Eliseo R, Convery K, Wood WC. Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. Cancer 1991; 67: 1504-1508 [PMID: 2001537]
38. Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M, Paty PB, Wong WD, Guillem JG. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 2004; 47: 1599-1606 [PMID: 15540287 DOI: 10.1007/ s10350-004-0677-x]
39. Min BS, Kim NK, Sohn SK, Cho CH, Lee KY, Baik SH. Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma. J Surg Oncol 2008; 97: 136-140 [PMID: 17963247 DOI: 10.1002/jso.20926]
40. Kelly H, Goldberg RM. Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol 2005; 23: 4553-4560 [PMID: 16002847 DOI: 10.1200/ JCO.2005.17.749]
41. Gwin JL, Hoffman JP, Eisenberg BL. Surgical management of nonhepatic intra-abdominal recurrence of carcinoma of the colon. Dis Colon Rectum 1993; 36: 540-544 [PMID: 7684666 DOI: 10.1007/BF02049858]
42. Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 2008; 18: 240-243 [PMID: 18725110 DOI: 10.1016/j.semradonc.2008.04.005]
43. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003; 300: 1155-1159 [PMID: 12750523 DOI: 10.1126/science.1082504]
44. García-Barros M, Thin TH, Maj J, Cordon-Cardo C, Haimovitz-Friedman A, Fuks Z, Kolesnick R. Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. Cancer Res 2010; 70: 8179-8186 [PMID: 20924105 DOI: 10.1158/0008-5472.CAN-10-1871]
45. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, André F, Delaloge S, Tursz T, Kroemer G, Zitvogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13: 1050-1059 [PMID: 17704786 DOI: 10.1038/ nm1622]
46. Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol 2005; 174: 7516-7523 [PMID: 15944250]
47. Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, Beckett M, Sharma R, Chin R, Tu T, Weichselbaum RR, Fu YX. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009; 114: 589-595 [PMID: 19349616 DOI: 10.1182/ blood-2009-02-206870]
48. Takaya M, Niibe Y, Tsunoda S, Jobo T, Imai M, Kotani S, Unno N, Hayakawa K. Abscopal effect of radiation on toruliform para-aortic lymph node metastases of advanced uterine cervical carcinoma--a case report. Anticancer Res 2007; 27: 499-503 [PMID: 17348433]
49. Okuma K, Yamashita H, Niibe Y, Hayakawa K, Nakagawa K. Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report. J Med Case Rep 2011; 5: 111 [PMID: 21418591 DOI: 10.1186/1752-1947-5-111]
50. Kingsley DP. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol 1975; 48: 863-866 [PMID: 811297]
51. Ohba K, Omagari K, Nakamura T, Ikuno N, Saeki S, Matsuo I, Kinoshita H, Masuda J, Hazama H, Sakamoto I, Kohno S. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut 1998; 43: 575-577 [PMID: 9824589]
52. Stamell EF, Wolchok JD, Gnjatic S, Lee NY, Brownell I. The abscopal effect associated with a systemic anti-melanoma immune response. Int J Radiat Oncol Biol Phys 2013; 85: 293-295 [PMID: 22560555 DOI: 10.1016/j.ijrobp.2012.03.017]
53. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, Formenti SC. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 2004; 58: 862-870 [PMID: 14967443 DOI: 10.1016/j.ijrobp.2003.09.012]
54. Dewan MZ, Galloway AE, Kawashima N, Dewyngaert JK, Babb JS, Formenti SC, Demaria S. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 2009; 15: 5379-5388 [PMID: 19706802 DOI: 10.1158/1078-0432.CCR-09-0265]
55. Kim MS, Cho CK, Yang KM, Lee DH, Moon SM, Shin YJ. Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer. World J Gastroenterol 2009; 15: 6091-6095 [PMID: 20027683 DOI: 10.3748/ wjg.15.6091]
56. Alongi F, Arcangeli S, Filippi AR, Ricardi U, Scorsetti M. Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist 2012; 17: 1100-1107 [PMID: 22723509 DOI: 10.1634/theoncologist.2012-0092]
57. Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, Chang TC, Fujita K, Oita M, Miyasaka K, Nishimura M, Dosaka-Akita H. Tolerance of organs at risk in smallvolume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003; 56: 126-135 [PMID: 12694831 DOI: 10.1016/ S0360-3016(03)00095-6]
58. Nagata Y, Wulf J, Lax I, Timmerman R, Zimmermann F, Stojkovski I, Jeremic B. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2011; 79: 660-669 [PMID: 21281896 DOI: 10.1016/ j.ijrobp.2010.10.004]
59. Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, Mizowaki T, Yano S, Hiraoka M. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008; 72: 398-403 [PMID: 18374506 DOI: 10.1016/j.ijrobp.2008.01.002]
60. Rubin P, Brasacchio R, Katz A. Solitary metastases: illusion versus reality. Semin Radiat Oncol 2006; 16: 120-130 [PMID: 16564447 DOI: 10.1016/j.semradonc.2005.12.007]
61. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 1996; 77: 1254-1262 [PMID: 8608500]
62. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986; 100: 278-284 [PMID: 3526605]
63. Greco C, Zelefsky MJ, Lovelock M, Fuks Z, Hunt M, Rosenzweig K, Zatcky J, Kim B, Yamada Y. Predictors of local control after single-dose stereotactic image-guided intensitymodulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys 2011; 79: 1151-1157 [PMID: 20510537 DOI: 10.1016/j.ijrobp.2009.12.038]
64. Milano MT, Katz AW, Muhs AG, Philip A, Buchholz DJ, Schell MC, Okunieff P. A prospective pilot study of curativeintent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008; 112: 650-658 [PMID: 18072260 DOI: 10.1002/cncr.23209]
65. Milano MT, Katz AW, Schell MC, Philip A, Okunieff P. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 1516-1522 [PMID: 18495378 DOI: 10.1016/j.ijrobp.2008.03.044]
66. Hoyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J, Nellemann H, Kiil Berthelsen A, Grau C, Aage Engelholm S, Von der Maase H. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006; 45: 823-830 [PMID: 16982546 DOI: 10.1080/02841860600904854]
67. Tree AC, Khoo VS, Eeles RA, Ahmed M, Dearnaley DP, Hawkins MA, Huddart RA, Nutting CM, Ostler PJ, van As NJ. Stereotactic body radiotherapy for oligometastases. Lancet Oncol 2013; 14: e28-e37 [PMID: 23276369 DOI: 10.1016/ S1470-2045(12)70510-7]
68. Kang JK, Kim MS, Kim JH, Yoo SY, Cho CK, Yang KM, Yoo HJ, Seo YS, Lee DH, Kang HJ, Kim YH, Shin US. Oligometastases confined one organ from colorectal cancer treated by SBRT. Clin Exp Metastasis 2010; 27: 273-278 [PMID: 20373133 DOI: 10.1007/s10585-010-9325-0]
69. Bae SH, Kim MS, Cho CK, Kang JK, Kang HJ, Kim YH, Shin US, Moon SM, Lee DH. High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases. J Surg Oncol 2012; 106: 138-143 [PMID: 22297789 DOI: 10.1002/jso.23058]
70. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, Yamashita T, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura T, Hirokawa Y, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara R, Itami J, Yamada K. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004; 101: 1623-1631 [PMID: 15378503 DOI: 10.1002/cncr.20539]
71. Choi CW, Cho CK, Yoo SY, Kim MS, Yang KM, Yoo HJ, Seo YS, Kang JK, Lee DH, Lee KH, Lee ED, Rhu SY, Choi SC, Kim MH, Kim BJ. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys 2009; 74: 147-153 [PMID: 18990511 DOI: 10.1016/j.ijrobp.2008.07.020]
72. Bignardi M, Navarria P, Mancosu P, Cozzi L, Fogliata A, Tozzi A, Castiglioni S, Carnaghi C, Tronconi MC, Santoro A, Scorsetti M. Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases. Int J Radiat Oncol Biol Phys 2011; 81: 831-838 [PMID: 20800375 DOI: 10.1016/j.ijrobp.2010.05.032]
73. Jereczek-Fossa BA, Fariselli L, Beltramo G, Catalano G, Serafini F, Garibaldi C, Cambria R, Brait L, Possanzini M, Bianchi LC, Vavassori A, Zerini D, Orsi F, de Cobelli O, Orecchia R. Linac-based or robotic image-guided stereotac-tic radiotherapy for isolated lymph node recurrent prostate cancer. Radiother Oncol 2009; 93: 14-17 [PMID: 19409636 DOI: 10.1016/j.radonc.2009.04.001]
74. Jereczek-Fossa BA, Piperno G, Ronchi S, Catalano G, Fodor C, Cambria R, Fossati Ing P, Gherardi F, Alterio D, Zerini D, Garibaldi C, Baroni G, De Cobelli O, Orecchia R. Linac-based Stereotactic Body Radiotherapy for Oligometastatic Patients With Single Abdominal Lymph Node Recurrent Cancer. Am J Clin Oncol 2012; Epub ahead of print [PMID: 22992626 DOI: 10.1097/COC.0b013e3182610878]
75. Kim MS, Choi C, Yoo S, Cho C, Seo Y, Ji Y, Lee D, Hwang D, Moon S, Kim MS, Kang H. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma. Jpn J Clin Oncol 2008; 38: 695-700 [PMID: 18723850 DOI: 10.1093/jjco/hyn083]
76. Kim MS, Yoo SY, Cho CK, Yoo HJ, Yang KM, Kang JK, Lee DH, Lee JI, Bang HY, Kim MS, Kang HJ. Stereotactic body radiotherapy for isolated para-aortic lymph node recurrence after curative resection in gastric cancer. J Korean Med Sci 2009; 24: 488-492 [PMID: 19543514 DOI: 10.3346/ jkms.2009.24.3.488]
77. Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, Höss A, Schlegel W, Wannenmacher MF. Stereotactic singledose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001; 19: 164-170 [PMID: 11134209]
78. Khalifa MA, Rowsell CH, Gladdy R, Ko YJ, Hanna S, Smith A, Law C. Is EGFR expression altered following postoperative chemotherapy for colorectal adenocarcinoma? World J Surg Oncol 2006; 4: 92 [PMID: 17163999 DOI: 10.1186/1477-7819-4-92]
79. Zlobec I, Vuong T, Compton CC, Lugli A, Michel RP, Hayashi S, Jass JR. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy. Br J Cancer 2008; 98: 450-456 [PMID: 18182986 DOI: 10.1038/sj.bjc.6604172]
80. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183-232 [PMID: 7612182 DOI: 10.1016/1040-8428(94)00144-I]
81. Van Schaeybroeck S, Karaiskou-McCaul A, Kelly D, Longley D, Galligan L, Van Cutsem E, Johnston P. Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy. Clin Cancer Res 2005; 11: 7480-7489 [PMID: 16243822 DOI: 10.1158/1078-0432.CCR-05-0328]
82. Bentzen SM, Atasoy BM, Daley FM, Dische S, Richman PI, Saunders MI, Trott KR, Wilson GD. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 2005; 23: 5560-5567 [PMID: 16110017 DOI: 10.1200/JCO.2005.06.411]
83. Eriksen JG, Steiniche T, Overgaard J. The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study. Radiother Oncol 2005; 74: 93-100 [PMID: 15816106 DOI: 10.1016/j.radonc.2004.12.018]
84. Timmerman RD. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 2008; 18: 215-222 [PMID: 18725106 DOI: 10.1016/j.semradonc.2008.04.001]
85. Bae SH, Kim MS, Kim SY, Jang WI, Cho CK, Yoo HJ, Kim KB, Lee DH, Han CJ, Yang KY, Kim SB. Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignancies. Int J Colorectal Dis 2013; 28: 1707-1713 [PMID: 23775098 DOI: 10.1007/s00384-013-1717-6]
86. Bae SH, Kim MS, Cho CK, Kang JK, Lee SY, Lee KN, Lee DH, Han CJ, Yang KY, Kim SB. Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies. Int J Radiat Oncol Biol Phys 2012; 84: e469-e474 [PMID: 23078899 DOI: 10.1016/ j.ijrobp.2012.06.005]
87. Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, McCarter MD, Burri S, Nedzi LA, Sawyer TE, Gaspar LE. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 2006; 45: 848-855 [PMID: 16982549 DOI: 10.1080/028418606009048 70]
88. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/ II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009; 27: 1572-1578 [PMID: 19255321 DOI: 10.1200/JCO.2008.19.6329]